Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $22.3150 (-2.3%) ($21.9300 - $22.3150) on Mon. Sep. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.77% (three month average) | RSI | 55 | Latest Price | $22.3150(-2.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.3% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) XBI(41%) IWO(40%) ARKG(39%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.385% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) IGOV(-8%) TBT(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.385% (StdDev 2.77%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $22.98 | 5 Day Moving Average | $23.37(-4.51%) | 10 Day Moving Average | $23.8(-6.24%) | 20 Day Moving Average | $22.98(-2.89%) | To recent high | -17.4% | To recent low | 8.7% | Market Cap | $3.268b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |